enGene Therapeutics (ENGN) Accumulated Expenses (2022 - 2026)
enGene Therapeutics (ENGN) posted Accumulated Expenses of $22.22 million for fiscal Q3 2026 (quarter ended Jul 31, 2026), up 99.9% from $11.12 million a year earlier and up 29.1% from the prior quarter.
Powered by 
Analysis
enGene Therapeutics (ENGN) Accumulated Expenses (2022 - 2026) Analysis & Trends
At the end of FY2025 (ended Oct 31, 2025), enGene Therapeutics' Accumulated Expenses came in at $15.28 million, up 25.9% from FY2024.
- Annual Accumulated Expenses has increased for three consecutive fiscal years, with a three-year compound annual growth rate of 69.9% (FY2022 to FY2025).
- In prior fiscal years, enGene Therapeutics' Accumulated Expenses was $12.13 million in FY2024 (+242.7%), $3.54 million in FY2023 (+13.6%) and $3.12 million in FY2022.
- The fiscal Q3 2026 figure stands as the highest quarterly Accumulated Expenses in data going back to fiscal Q4 2022.
- On a year-over-year basis, Accumulated Expenses has increased in each of the last eight quarters, with growth averaging 93.5% over the last eight quarters.
- Over the past five years, the year-over-year growth in Accumulated Expenses ranged from 13.6% (fiscal Q4 2023) to 242.7% (fiscal Q4 2024).
- According to Business Quant data, Accumulated Expenses for the three prior fiscal quarters was $17.21 million (Q2 2026), $19.67 million (Q1 2026) and $15.28 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | enGene Therapeutics | 105.88 Mn | -888.59 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 22.22 Mn |
| Apr 30, 2026 | 17.21 Mn |
| Jan 31, 2026 | 19.67 Mn |
| Oct 31, 2025 | 15.28 Mn |
| Jul 31, 2025 | 11.12 Mn |
| Apr 30, 2025 | 12.43 Mn |
| Jan 31, 2025 | 8.24 Mn |
| Oct 31, 2024 | 12.13 Mn |
| Jul 31, 2024 | 8.83 Mn |
| Apr 30, 2024 | 5.67 Mn |
| Jan 31, 2024 | 5.24 Mn |
| Oct 31, 2023 | 3.54 Mn |
| Oct 31, 2022 | 3.12 Mn |
API Access
enGene Therapeutics Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();